Document:

Registration Rights Agreement

 Exhibit 4.01 
 REGISTRATION RIGHTS AGREEMENT 

 TABLE OF CONTENTS 

 

									
	 	    	 	    	 	 	Page	 
			
	1.	    	REGISTRATION RIGHTS	 	 	1	  
				
		    	1.1	    	Definitions	 	 	1	  
				
		    	1.2	    	Shelf Registration	 	 	2	  
				
		    	1.3	    	Obligations of the Buyer	 	 	3	  
				
		    	1.4	    	Information from Holders	 	 	4	  
				
		    	1.5	    	Expenses of Registration	 	 	4	  
				
		    	1.6	    	Delay of Registration	 	 	4	  
				
		    	1.7	    	Indemnification	 	 	5	  
				
		    	1.8	    	Reports Under the 1934 Act	 	 	7	  
				
		    	1.9	    	Assignment of Registration Rights	 	 	7	  
				
		    	1.10	    	Termination of Registration Rights	 	 	8	  
			
	2.	    	MISCELLANEOUS	 	 	8	  
				
		    	2.1	    	Successors and Assigns	 	 	8	  
				
		    	2.2	    	Governing Law	 	 	8	  
				
		    	2.3	    	Counterparts	 	 	8	  
				
		    	2.4	    	Remedies	 	 	8	  
				
		    	2.5	    	Titles and Subtitles	 	 	9	  
				
		    	2.6	    	Notices	 	 	9	  
				
		    	2.7	    	Expenses	 	 	10	  
				
		    	2.8	    	Entire Agreement; Amendments and Waivers	 	 	10	  
				
		    	2.9	    	Severability	 	 	10	  
				
		    	2.10	    	Aggregation of Stock	 	 	10	  

  
 i 

 REGISTRATION RIGHTS AGREEMENT 

This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is dated as of November 18, 2010, among Ariba, Inc., a
Delaware corporation (“Buyer”); Quadrem International Holdings, Ltd., a Bermuda exempted company (Registration No. EC28900) (the “Company”); and Charlotte, Ltd., a Bermuda exempted company (Registration No. EC
30460), as Stockholders’ Representative (the “Stockholders’ Representative”). Terms not otherwise defined herein have the meaning given to them in the Purchase Agreement (as defined below). 

THE PARTIES TO THIS AGREEMENT enter into this Agreement on the basis of the following facts, intentions and understandings:

 WHEREAS, the Buyer, the Company and the Stockholders’ Representative are parties to the Stock Purchase Agreement
dated November 18, 2010 (the “Purchase Agreement”) and the Company is sometimes referred to herein as the “Seller”; and 
 WHEREAS, it is contemplated that the Company shall give certain Company Stockholders the choice of receiving Buyer Shares issued to the Company pursuant to Section 2.01(a)(i) of the Purchase
Agreement or proceeds from the Company’s sale of such Buyer Shares. 
 WHEREAS, in order to induce the Seller to
enter into the Purchase Agreement, Buyer and the Seller concurrently entered into this Agreement to grant the Company the registration rights set forth herein with respect to the Buyer Shares issued to the Company pursuant to Section 2.01(a)(i)
of the Purchase Agreement. 
 NOW, THEREFORE, the parties hereby agree as follows: 

1. Registration Rights. The Buyer covenants and agrees as follows: 

1.1 Definitions. For purposes of this Section 1: 
 (a) The term “Act” means the Securities Act of 1933, as amended. 

(b) The term “Anniversary Date” means the first anniversary of the date of this Agreement. 

(c) The term “Form S-3” means such form under the Act as in effect on the date hereof or any successor registration
form under the Act subsequently adopted by the SEC. 
 (d) The term “Holders” means the Company and any
assignee thereof in accordance with Section 1.9 hereof. 
 (e) The term “1934 Act” means the Securities
Exchange Act of 1934, as amended. 

 (f) The terms “register,” “registered,” and
“registration” refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or
document. 
 (g) The term “Registrable Securities” means (i) the Buyer Shares issued to the Company
pursuant to Section 2.01(a)(i) of the Purchase Agreement, and (ii) any Buyer Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution
with respect to, or in exchange for, or in replacement of, the shares referenced in (i) above, excluding in all cases, however, any Registrable Securities sold by a person in a transaction in which his rights under this Section 1 are not
assigned. 
 (h) The term “Rule 144” shall mean Rule 144 under the Act (or any successor rule). 

(i) The term “SEC” shall mean the Securities and Exchange Commission. 

1.2 Shelf Registration. 
 (a) As soon as practicable after the date hereof, the Buyer will prepare and file with the SEC a registration statement on Form S-3 for the purpose of registering under the Securities Act all of the
Registrable Securities for resale by, and for the account of, the Holders as selling stockholders thereunder (the “Shelf Registration Statement”). The Shelf Registration Statement shall permit the Holders to offer and sell, on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act, any or all of the Registrable Securities. The Buyer agrees to use commercially reasonable efforts to cause the Shelf Registration Statement to become effective as soon as
reasonably possible and, subject to Section 1.2(b), to remain effective until all of such Registrable Securities have been disposed of. 
 (b) The Buyer shall be required to keep the Shelf Registration Statement effective until such date that is the earlier of (i) the date as of which each Holder may sell all of the Registrable
Securities without restriction pursuant to Rule 144 promulgated under the Securities Act, assuming that such Holder is not an affiliate of Buyer, or (ii) the date when all of the Registrable Securities registered thereunder shall have been sold
pursuant to the Shelf Registration Statement or Rule 144. Thereafter, the Buyer shall be entitled to withdraw the Shelf Registration Statement and the Holders shall have no further right to offer or sell any of the Registrable Securities pursuant to
the Shelf Registration Statement (or any prospectus relating thereto). 

  
 2 

 1.3 Obligations of the Buyer. Except as otherwise expressly provided herein, and in
addition to its obligations in Section 1.2, the Buyer shall, as expeditiously as reasonably possible: 
 (a) prepare and
file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition of
all securities covered by such registration statement; 
 (b) furnish to the Holders such number of copies of a prospectus,
including a preliminary prospectus, in conformity with the requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

(c) use all commercially reasonable efforts to register and qualify the securities covered by such registration statement under such
other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Buyer shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions; 
 (d) notify the Holders covered by such
registration statement at any time when a prospectus relating thereto is required to be delivered under the Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an
untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing; 

(e) cause all such Registrable Securities registered pursuant to this Section 1 to be listed on the Nasdaq Stock Market, Inc.
Global Market, the New York Stock Exchange or another market reasonably acceptable to the Company; and 
 (f) provide a
transfer agent and registrar for all Registrable Securities registered pursuant hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration. 

Notwithstanding the provisions of this Section 1, the Buyer shall be entitled to postpone or suspend the filing, effectiveness or
use of, or trading under, any registration statement during any period when (i) the Buyer is not eligible to use Form S-3, (ii) the SEC or The Nasdaq Stock Market requests that the Buyer amend or supplement the Shelf Registration Statement
or the prospectus included therein or requests additional information relating thereto, (iii) the SEC or The Nasdaq Stock Market issues a stop order or similar order suspending the effectiveness or restricting the use of the Shelf Registration
Statement or initiates proceedings to issue a stop order or similar order, or (iv) the Board of Directors of the Buyer in good faith determines that the Shelf Registration Statement, the prospectus included therein, any amendment or supplement
thereto or any document incorporated or deemed to be incorporated therein contains an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading, in
light of the circumstances then existing; provided, however, that the Buyer uses commercially reasonable efforts to prepare and file with the SEC such amendments and supplements to the such registration statement or amendment as shall
be reasonably necessary to cure such untrue statement or omission, provided, however, that during any such period all executive officers and directors of the Buyer and all stockholders of the Buyer with similar registration rights are
also prohibited from selling securities of the Buyer or (v) the Board of Directors of Buyer in good faith determines that the failure to so postpone or suspend would require disclosure of material nonpublic information that, if disclosed at
such time, would be materially harmful to the interests of Buyer and its stockholders; provided, however, that during any such period all executive officers and directors of Buyer and all stockholders of Buyer with similar registration
rights are also prohibited from selling securities of Buyer; provided, further, however, that such postponement or suspension (A) shall not occur during the first forty (40) days after Closing, (B) shall not
exceed a period of forty (40) days and (C) shall be exercised by Buyer not more than twice during the subsequent one hundred forty (140) day period (for a maximum of forty-five (45) days within such one hundred forty
(140) day period), provided that the second period of postponement or suspension within such one hundred forty (140) day period shall not commence less than sixty (60) days after the end of the first period of postponement or
suspension within such one hundred forty (140) day period. In the event of the suspension of effectiveness of any registration statement pursuant to this Section 1.3, the applicable time period during which such registration statement is
to remain effective shall be extended by that number of days equal to the number of days the effectiveness of such registration statement was suspended. 

  
 3 

 1.4 Information from Holders. It shall be a condition precedent to the obligations of
the Buyer to take any action pursuant to this Section 1 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Buyer such information regarding itself, the Registrable Securities held by it, and
the intended method of disposition of such securities as shall be reasonably required to effect the registration of such Holder’s Registrable Securities. 
 1.5 Expenses of Registration. All expenses (other than (i) underwriting discounts and commissions relating to the Registrable Securities that are being sold by the Holders and (ii) fees
of any counsel for the selling Holders) that are incurred in connection with registrations, filings or qualifications pursuant to Section 1.2, including (without limitation) all registration, filing and qualification fees, printers’ and
accounting fees, fees and disbursements of counsel for the Buyer shall be borne by the Buyer. 
 1.6 Delay of
Registration. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this
Section 1. 

  
 4 

 1.7 Indemnification. In the event any Registrable Securities are included in a
registration statement under this Section 1: 
 (a) To the extent permitted by law, the Buyer will indemnify and hold
harmless each Holder, the partners, officers, directors and stockholders of each Holder, legal counsel and accountants for each Holder, any underwriter (as defined in the Act) for such Holder and each person, if any, who controls such Holder or
underwriter within the meaning of the Act or the 1934 Act, against any losses, claims, damages or liabilities (joint or several) to which they may become subject under the Act, the 1934 Act, any state securities laws or any rule or regulation
promulgated under the Act, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”):
(i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the
omission or alleged omission to state in such registration statement a material fact required to be stated therein, or necessary to make the statements therein not misleading or (iii) any violation or alleged violation by the Buyer of the Act,
the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws, and the Buyer will reimburse each such Holder, underwriter, controlling person or other aforementioned person for
any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that the indemnity agreement
contained in this subsection l.8(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Buyer (which consent shall not be unreasonably
withheld), nor shall the Buyer be liable to a person claiming indemnification in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation that (i) occurs in reliance
upon and in conformity with written information furnished expressly for use in connection with such registration by such Holder, underwriter, controlling person or other aforementioned person that is claiming indemnification or (ii) incurs in
reliance on financial statements of the Company or any of its Subsidiaries furnished to Buyer pursuant to the Purchase Agreement or derived by Buyer from such financial statements and included or incorporated by reference into the Shelf Registration
Statement; provided, further, however, that the foregoing indemnity agreement with respect to any preliminary prospectus shall not inure to the benefit of any such Holder or underwriter or other aforementioned person, or any
person controlling such Holder or underwriter, from whom the person asserting any such losses, claims damages or liabilities purchased shares in the offering, if a copy of the most current prospectus was not sent or given by or on behalf of such
Holder or underwriter or other aforementioned person to such person, if required by law to have been so delivered, at or prior to the written confirmation of the sale of the shares of such person, and if the prospectus (as so amended or
supplemented) would have cured the defect giving rise to such loss, claim, damage or liability. 
 (b) To the extent permitted
by law, each selling Holder will, severally and not jointly, indemnify and hold harmless the Buyer, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Buyer within the meaning
of the Act, legal counsel and accountants for the Buyer, any underwriter, any other Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any losses, claims, damages or
liabilities (joint or several) to which any of the foregoing persons may become subject, under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws, insofar
as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation (i) occurs in reliance upon and in conformity
with written information furnished by such Holder expressly for use in connection with such registration or (ii) incurs in reliance on financial statements of the Company or any of its Subsidiaries furnished to Buyer pursuant to the Purchase
Agreement or derived by Buyer from such financial statements and included or incorporated by reference into the Shelf Registration Statement; and each such Holder will reimburse any person intended to be indemnified pursuant to this subsection
1.7(b) for any legal or other expenses reasonably incurred by such person in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that the
indemnity agreement contained in this subsection 1.7(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder (which consent shall not be
unreasonably withheld), and provided that in no event shall any indemnity under this subsection 1.7(b) exceed the net proceeds from the offering received by such Holder. 

  
 5 

 (c) Promptly after receipt by an indemnified party under this Section 1.7 of notice of
the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 1.7, deliver to the indemnifying party a written
notice of the commencement thereof and the indemnifying party shall have the right to participate in and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof
with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one
separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests
between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its
ability to defend such action, shall relieve such indemnifying party of liability to the indemnified party under this Section 1.7 to the extent of such prejudice, but the omission to so deliver written notice to the indemnifying party will not
relieve it of any liability that it may have to any indemnified party otherwise than under this Section 1.7. 
 (d) If the
indemnification provided for in this Section 1.7 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying
party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect
the relative fault of the indemnifying party on the one hand and the indemnified party on the other hand in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant
equitable considerations; provided, however, that no contribution by any Holder, when combined with any amounts paid by such Holder pursuant to Section 1.7(b), shall exceed the net proceeds from the offering received by such
Holder. The relative fault of the indemnifying party and the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 

(e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting
agreement entered into by any Holder claiming indemnification in connection with an underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control with respect to such Holder.

  
 6 

 (f) The obligations of the Buyer and Holders under this Section 1.7 shall survive the
completion of any offering of Registrable Securities in a registration statement under this Section 1 and otherwise. 
 1.8
Reports Under the 1934 Act. With a view to making available to the Holders the benefits of Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Buyer to the public without
registration, the Buyer agrees, to: 
 (a) make and keep public information available, as those terms are understood and
defined in Rule 144; 
 (b) file with the SEC in a timely manner all reports and other documents required of the Buyer under
the Act and the 1934 Act; 
 (c) file with the SEC all reports and other documents required of the Buyer under the Act and the
1934 Act; and 
 (d) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request
(i) a written statement by the Buyer that it has complied with the reporting requirements of Rule 144, (ii) a copy of the most recent annual or quarterly report of the Buyer and such other reports and documents so filed by the Buyer, and
(iii) such other information as may be reasonably requested to avail any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration on or after the Anniversary Date. 

1.9 Assignment of Registration Rights. The rights to cause Buyer to register Registrable Securities pursuant to this
Section 1 may be assigned (but only with all related obligations) (i) by the Company to a successor in interest or liquidating trust established by the Company, (ii) by the Company, such successor in interest or such liquidating trust
to any Company Stockholder or (iii) by a Company Stockholder to (A) a direct or indirect wholly-owned subsidiary of such Company Stockholder, (B) a parent of such Company Stockholder that directly or indirectly owns 100% of the equity
of such Company Stockholder or (C) in the case of a Company Stockholder that is a natural person, to such Company Stockholder’s immediate family member (spouse or child) or trust for the benefit of such an immediately family member,
provided that within five (5) business days prior to the effective date of such assignment: (a) the Company and Buyer are furnished with written notice of the name and address of such assignee and the Registrable Securities with respect to
which such registration rights are being assigned; and (b) such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement (including the obligations of the assigning Company Stockholder
hereunder with respect to such Registrable Securities) and to designate the Stockholders’ Representative as its exclusive representative, agent and attorney-in-fact pursuant to Section 9.04 of the Purchase Agreement, such written agreement
to be reasonably satisfactory to the Company and Buyer. 

  
 7 

 1.10 Termination of Registration Rights. No Holder shall be entitled to exercise any
right provided for in this Section 1 (i) after two (2) years following the date of this Agreement, (ii) at such time as such Holder may sell all of its Registrable Securities with restriction pursuant to Rule 144 promulgated
under the Securities Act or (iii) after such time at which such Holder receives freely-tradable securities in connection with any consolidation, reorganization or merger of the Buyer with or into any other corporation or corporations or a sale,
conveyance, or other disposition of all or substantially all of the Buyer’s property or business. 
 2.
Miscellaneous. 
 2.1 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this
Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties (including transferees of any shares of Registrable Securities). Nothing in this Agreement, express or implied, is intended to confer
upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 

2.2 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without
reference to such state’s principles of conflicts of law. The parties hereto hereby irrevocably submit to the exclusive jurisdiction of the courts of the State of New York and the Federal courts of the United States of America located within
the City of New York in the State of New York, in respect of the interpretation and enforcement of the provisions of this Agreement and of the documents referred to in this Agreement, and in respect of the transactions contemplated hereby and
thereby, and hereby waive, and agree not to assert, as a defense in any action, suit or Proceeding for the interpretation or enforcement hereof or thereof, that it is not subject thereto or that such action, suit or Proceeding may not be brought or
is not maintainable in said courts or that the venue thereof may not be appropriate or that this Agreement or any such document may not be enforced in or by such courts, and the parties hereto irrevocably agree that all claims with respect to such
action or Proceeding shall be heard and determined in such a New York State or Federal court. The parties hereby consent to and grant any such court jurisdiction over the person of such parties and over the subject matter of such dispute and agree
that mailing of process or other papers in connection with any such action or Proceeding in the manner provided in Section 2.6 or in such other manner as may be permitted by applicable Law, shall be valid and sufficient service thereof. With
respect to any particular action, suit or Proceeding, venue shall lie solely in the City of New York, New York. 
 2.3
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

2.4 Remedies. Each Holder shall be entitled to enforce its rights under this Agreement specifically to recover damages and costs
(including reasonable attorney’s fees) for any breach of any provision of this Agreement and to exercise all other rights existing in its favor. The parties hereto agree and acknowledge that money damages are not an adequate remedy for any
breach of the provisions of this Agreement and that the Holders are entitled to specific performance and/or other injunctive relief (without posting any bond or deposit) in order to enforce or prevent any violations of the provisions of this
Agreement. 

  
 8 

 2.5 Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement. 
 2.6 Notices. All
notices, requests, claims, demands and other communications hereunder shall be in writing and shall be deemed given if delivered personally or by commercial delivery service, or mailed by registered or certified mail (return receipt requested) or
sent via facsimile (with confirmation of receipt) to the parties hereto at the following address (or at such other address for a party as shall be specified in a notice given in accordance with this Section 2.6): 

 

	 	(a)	if to Buyer: 

Ariba, Inc. 

807 11th Avenue 
 Sunnyvale, CA 94089 
 Attention: David Middler 

Facsimile No.: (650) 390-1377 

Telephone No.: (650) 390-1000 

with a copy to: 
 Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP 
 1200 Seaport Boulevard 
 Redwood City, California 94063

 Attention: Brooks Stough 

Telephone: (650) 463-5370 
 Facsimile No.: (650) 321-2800 
  

	 	(b)	if to the Company: 

 QUADREM INTERNATIONAL HOLDINGS LTD. 
 c/o Conyers Dill &
Pearman Limited 
 Clarendon House, 2 Church Street 

PO BOX HM 666, Hamilton HM CX, Bermuda 

Attention: Christopher Page 
 Telephone: +1 (441) 295 1422 
 Facsimile No.: +1
(441) 198 7809 
 with a copy to: 

Morrison & Foerster LLP 

555 West Fifth Street, Suite 3500 

Los Angeles, CA 90013-1024 
 Attn: Hillel T. Cohn 
 Telephone: (213) 892-5251 

Facsimile No.: (213) 892-5454 

  
 9 

	 	(c)	if to the Stockholder’s Representative: 

 Charlotte, Ltd. 
 c/o Conyers Dill & Pearman Limited

 Clarendon House, 2 Church Street 

PO BOX HM 666, Hamilton HM CX, Bermuda 

Attention: Christopher Page 
 Telephone: +1 (441) 295 1422 
 Facsimile No.: +1
(441) 198 7809 
 with a copy to: 

Morrison & Foerster LLP 

555 West Fifth Street, Suite 3500 

Los Angeles, CA 90013-1024 
 Attn: Hillel T. Cohn 
 Telephone: (213) 892-5251 

Facsimile No.: (213) 892-5454 
 2.7 Expenses. If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs
and necessary disbursements in addition to any other relief to which such party may be entitled. 
 2.8 Entire Agreement;
Amendments and Waivers. This Agreement and the Purchase Agreement constitutes the full and entire understanding and agreement among the parties with regard to the subjects hereof. Any term of this Agreement may be amended and the observance of
any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Buyer, the Company and the Stockholder Representative. Any amendment or waiver
effected in accordance with this paragraph shall be binding upon each holder of any Registrable Securities, each future holder of all such Registrable Securities, and the Company. 

2.9 Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such Provision(s)
shall be excluded from this Agreement and the balance of this Agreement shall be interpreted as if such provision(s) were so excluded and shall be enforceable in accordance with its terms. 

2.10 Aggregation of Stock. All shares of Registrable Securities held or acquired by affiliated entities (including affiliated
venture capital funds) or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. 

  
 10 

 IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written. 
  

			
	ARIBA, INC.
		
	By:	 	 /s/ David Middler

	Name:	 	David Middler
	Title:	 	Secretary and General Counsel

 IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written. 
  

			
	QUADREM INTERNATIONAL HOLDINGS, LTD.
		
	 By:
	 	 /s/ Charles Jackson, Jr.

	 Name:
	 	Charles Jackson, Jr.
	 Title:
	 	Chief Executive Officer

 IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the
date first above written. 
  

			
	CHARLOTTE, LTD.
		
	By:	 	 /s/ Brian Williams

	Name:	 	Brian Williams
	Title:	 	DirectorForm of Restricted Stock Agreement

 Exhibit 10.1 
 THE ALTRIA GROUP, INC. 
 2010 PERFORMANCE INCENTIVE PLAN 

RESTRICTED STOCK AGREEMENT 
 (January 25, 2011) 
 ALTRIA GROUP, INC. (the “Company”), a
Virginia corporation, hereby grants to the employee identified in the 2011 Restricted Stock Award section of the Award Statement (the “Employee”) under the Altria Group, Inc. 2010 Performance Incentive Plan (the “Plan”) a
Restricted Stock Award (the “Award”) dated January 25, 2011 (the “Award Date”), with respect to the number of shares of the Common Stock of the Company (the “Common Stock”) set forth in the 2011 Restricted Stock
Award section of the Award Statement (the “Shares”), all in accordance with and subject to the following terms and conditions of this Restricted Stock Agreement (the “Agreement”): 

1. Book Entry Registration. The Shares shall be evidenced by a book entry account maintained by the Company’s Transfer Agent
for the Common Stock. Upon the vesting of Shares, no certificates will be issued except upon a separate written request made to such Transfer Agent or other agent as determined by the Company. 

2. Condition to Award. As applicable and in the sole discretion of the Company or its delegate, this Award may be contingent on,
and in consideration of, the execution of a Confidentiality and Non-Competition Agreement by the Employee. In the event the Employee is required to execute a Confidentiality and Non-Competition Agreement, the Company or its delegate will so notify
the Employee prior to issuance of the Award. If the Employee does not execute the Confidentiality and Non-Competition Agreement within a reasonable time frame established by the Company or its delegate, but no later than 90 days after the Award
Date, this Agreement will be null and void with respect to the Employee and the Employee will forfeit any and all rights to the Award. 
 3. Restrictions. Subject to Section 2 above and Section 4 below, the restrictions on the Shares shall lapse and the Shares shall vest on the vesting date set forth in the 2011 Restricted
Stock Award section of the Award Statement (the “Vesting Date”), provided that the Employee remains an employee of the Company (or a subsidiary or affiliate) during the entire period (the “Restriction Period”) commencing on the
Award Date and ending on the Vesting Date. 
 4. Termination of Employment During Restriction Period. In the event of the
termination of the Employee’s employment with the Company (and with all subsidiaries and affiliates of the Company) prior to the Vesting Date due to death or Disability, or upon the Employee reaching eligibility for Normal Retirement, the
restrictions on the Shares shall lapse and the Shares shall become fully vested on the date of death, Disability, or eligibility for Normal Retirement. 
 If the Employee’s employment with the Company (and with all subsidiaries and affiliates of the Company) is terminated for any reason other than death or Disability prior to the end of the Restriction
Period, the Employee shall forfeit all rights to the Shares immediately after termination of employment. Notwithstanding the foregoing, the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”) may,
in its sole discretion, waive the restrictions on, and the vesting requirements for, the Shares. 
 5. Voting and Dividend
Rights. During the Restriction Period, the Employee shall have the rights to vote the Shares and to receive any cash dividends payable with respect to the Shares, as paid, less applicable withholding taxes. 

 6. Transfer Restrictions. This Award and the Shares (until they become unrestricted
pursuant to the terms hereof) are non-transferable and may not be assigned, hypothecated or otherwise pledged and shall not be subject to execution, attachment or similar process. Upon any attempt to effect any such disposition, or upon the levy of
any such process, the Award shall immediately become null and void, and the Shares shall be forfeited. 
 7. Withholding
Taxes. The Company is authorized to satisfy the actual minimum statutory withholding taxes arising from the granting or vesting of this Award, as the case may be, by deducting the number of Shares having an aggregate value equal to the amount of
withholding taxes due from the total number of Shares awarded or the number of Shares vesting or otherwise becoming subject to current taxation. The Company is also authorized to satisfy the actual withholding taxes arising from the granting or
vesting of this Award, or hypothetical withholding tax amounts if the Employee is covered under a Company tax equalization policy, as the case may be, by the remittance of the required amounts from any proceeds realized upon the open-market sale of
vested Shares by the Employee. Shares deducted from this Award in satisfaction of actual minimum statutory withholding tax requirements shall be valued at the Fair Market Value of the Shares on the date as of which the amount giving rise to the
withholding requirement first became includible in the gross income of the Employee under applicable tax laws. If the Employee is covered by a Company tax equalization policy, the Employee also agrees to pay to the Company any additional
hypothetical tax obligation calculated and paid in accordance with such tax equalization policy. 
 8. Death of Employee.
If any of the Shares shall vest upon the death of the Employee, they shall be registered in the name of the estate of the Employee except that, to the extent permitted by the Compensation Committee, if the Company shall have theretofore received in
writing a beneficiary designation, the Shares shall be registered in the name of the designated beneficiary. 
 9. Board
Authorization in the Event of Restatement. Notwithstanding anything in this Agreement to the contrary, if the Board of Directors of the Company or an appropriate Committee of the Board determines that, as a result of a restatement of the
Company’s financial statements, the Employee has received greater compensation in connection with the Award than would been received absent the incorrect financial statements, the Board or Committee, in its discretion, may take such action with
respect to this Award as it deems necessary or appropriate to address the events that gave rise to the restatement and to prevent its recurrence. Such action may include, to the extent permitted by applicable law, causing the full or partial
cancellation of this Award and, with respect to Shares that have vested, requiring the Employee to repay to the Company the full or partial Fair Market Value of the Award determined at the time of vesting, and the Employee agrees by accepting this
Award that the Board or Committee may make such a cancellation, impose such a repayment obligation, or take other necessary or appropriate actions in such circumstances. 
 10. Other Terms and Provisions. The terms and provisions of the Plan (a copy of which will be furnished to the Employee upon written request to the Office of the Corporate Secretary, Altria Group,
Inc., 6601 West Broad Street, Richmond, Virginia 23230) are incorporated herein by reference. To the extent any provision of this Award is inconsistent or in conflict with any term or provision of the Plan, the Plan shall govern. Capitalized terms
not otherwise defined herein have the meaning set forth in the Plan. Subject to the provisions of section 6(a) of the Plan, in the event of any merger, share exchange, reorganization, consolidation, recapitalization, reclassification, distribution,
stock dividend, stock split, reverse stock split, split-up, spin-off, issuance of rights or warrants or other similar transaction or event affecting the Common Stock after the date of this Award, the Board of Directors of the Company is authorized,
to the extent it deems appropriate, to make adjustments to the number and kind of shares of stock subject to this Award, including the substitution of equity interests in other entities involved in such transactions, to provide for cash payments in
lieu of Shares, and to determine whether continued 

  
 2 

 
employment with any entity resulting from such a transaction will or will not be treated as continued employment with the Company and its subsidiaries and affiliates, in each case subject to any
Board or Compensation Committee action specifically addressing any such adjustments, cash payments, or continued employment treatment. 
 For purposes of this Agreement, (a) the term “Disability” means permanent and total disability as determined under procedures established by the Company for purposes of the Plan, and
(b) the term “Normal Retirement” means retirement from active employment under a pension plan of the Company or any subsidiary or affiliate of the Company or under an employment contract with the Company or any subsidiary or affiliate
of the Company on or after the date specified as the normal retirement age in the pension plan or employment contract, if any, under which the Employee is at that time accruing pension benefits for his or her current service (or, in the absence of a
specified normal retirement age, the age at which pension benefits under such plan or contract become payable without reduction for early commencement and without any requirement of a particular period of prior service). In any case in which
(i) the meaning of “Normal Retirement” is uncertain under the definition contained in the prior sentence or (ii) a termination of employment at or after age 65 would not otherwise constitute “Normal Retirement,” an
Employee’s termination of employment shall be treated as a “Normal Retirement” under such circumstances as the Compensation Committee, in its sole discretion, deems equivalent to retirement. Generally, for purposes of this Agreement,
(x) a “subsidiary” includes only any company in which the Company, directly or indirectly, has a beneficial ownership interest of greater than 50 percent and (y) an “affiliate” includes only any company that
(A) has a beneficial ownership interest, directly or indirectly, in the Company of greater than 50 percent or (B) is under common control with the Company through a parent company that, directly or indirectly, has a beneficial ownership
interest of greater than 50 percent in both the Company and the affiliate. 
 IN WITNESS WHEREOF, this Restricted Stock
Agreement has been duly executed as of January 25, 2011. 
  

			
	ALTRIA GROUP, INC.
		
	By:	 	 W. Hildebrandt Surgner, Jr.
 Corporate Secretary

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}]]